Kolexia
Fitoussi Olivier Oncologie hémato.
Fitoussi Olivier
Oncologie hémato.
Clinique D'arcachon
La Teste-de-Buch, France
136 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Myélome multiple Récidive tumorale locale Lymphome folliculaire Translocation génétique Lymphome malin non hodgkinien Anémie

Collaborateurs

Voir plus
Tilly Herve
Tilly Herve
Centre Henri-Becquerel, Rouen, France
Haioun Corinne
Haioun Corinne
Hôpital Henri Mondor, Créteil, France
Salles Gilles
Salles Gilles
Hôpital Lyon Sud, Pierre-Bénite, France
Delarue Richard
Delarue Richard
Hôpital Necker Enfants Malades, Paris, France

Industries

Voir plus
Janssen
24 collaboration(s)
Dernière en 2023
A+A
12 collaboration(s)
Dernière en 2021
Abbvie
10 collaboration(s)
Dernière en 2023
Novartis
9 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Identification and Clinical Characterization of CNS Relapse in DLBCL Patients across 19 Prospective Phase 2 and 3 Trials - a GLA/ DSHNHL and LYSA Collaboration
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Simplified IPI Including BCL2 Identifies IPI 3 Patients with Poor Prognosis - a GLA/ Dshnhl and Lysa Collaboration
65th ASH Annual Meeting Abstracts   02 novembre 2023
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood advances   24 octobre 2023
TRANSCRIPT: Transplantation After Complete Response In Patients With T-cell Lymphoma
Essai Clinique (Hospices Civils de Lyon)   26 septembre 2023
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis.
Blood advances   31 juillet 2023
Quality of life and response shift effect of diffuse large B-cell lymphoma French patients included in prospective real-life REALYSA cohort in the first year after diagnosis
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   18 avril 2023
Accuracy of FDG-PET/CT for Response Evaluation of Muscle-Invasive Bladder Cancer following Neoadjuvant or Induction Chemotherapy.
Urologia internationalis   19 janvier 2023
FLIRT: A Randomized Phase III Trial Evaluating Two Strategies of Rituximab Administration for the Treatment of First Line/Low Tumor Burden Follicular Lymphoma (Follicular Lymphoma IV/SC Rituximab Therapy)
Essai Clinique (Roche)   09 janvier 2023
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial.
Blood advances   21 décembre 2022